John W. Smither
2018
In 2018, John W. Smither earned a total compensation of $2.7M as Chief Financial Officer at Sienna Biopharmaceuticals, a 1,541% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $89,409 |
|---|---|
| Option Awards | $2,326,117 |
| Salary | $255,000 |
| Total | $2,670,526 |
Smither received $2.3M in option awards, accounting for 87% of the total pay in 2018.
Smither also received $89.4K in non-equity incentive plan and $255K in salary.
Rankings
In 2018, John W. Smither's compensation ranked 4,378th out of 14,244 executives tracked by ExecPay. In other words, Smither earned more than 69.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,378 out of 14,244 | 69th |
Division Manufacturing | 1,629 out of 5,762 | 72nd |
Major group Chemicals And Allied Products | 585 out of 2,125 | 73rd |
Industry group Drugs | 489 out of 1,814 | 73rd |
Industry Pharmaceutical Preparations | 381 out of 1,388 | 73rd |
Source: SEC filing on April 11, 2019.
Smither's colleagues
We found two more compensation records of executives who worked with John W. Smither at Sienna Biopharmaceuticals in 2018.